Xinling Liang

5.9k total citations
159 papers, 2.5k citations indexed

About

Xinling Liang is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, Xinling Liang has authored 159 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Nephrology, 37 papers in Molecular Biology and 26 papers in Epidemiology. Recurrent topics in Xinling Liang's work include Renal Diseases and Glomerulopathies (38 papers), Acute Kidney Injury Research (35 papers) and Chronic Kidney Disease and Diabetes (27 papers). Xinling Liang is often cited by papers focused on Renal Diseases and Glomerulopathies (38 papers), Acute Kidney Injury Research (35 papers) and Chronic Kidney Disease and Diabetes (27 papers). Xinling Liang collaborates with scholars based in China, United States and Japan. Xinling Liang's co-authors include Shuangxin Liu, Yuanhan Chen, Ruizhao Li, Zhiming Ye, Zheng Dong, Wenjian Wang, Zhilian Li, Chunyuan Guo, Guie Dong and Xingchen Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Xinling Liang

148 papers receiving 2.5k citations

Peers

Countries citing papers authored by Xinling Liang

Since Specialization

Citations

This map shows the geographic impact of Xinling Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinling Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinling Liang more than expected).

Fields of papers citing papers by Xinling Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinling Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinling Liang. The network helps show where Xinling Liang may publish in the future.

Co-authorship network of co-authors of Xinling Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinling Liang. A scholar is included among the top collaborators of Xinling Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinling Liang. Xinling Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-Cell RNA Sequencing Reveals Peritoneal Environment and New Insights into Fibrosis in a Continuous Ambulatory Peritoneal Dialysis Patient: A Longitudinal Self-Controlled Study from Dialysis Initiation to 3-Year Follow-Up 2025 ·Kidney Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jintao He, (unknown), (unknown), Wenxue Hu, Xinling Liang	0
2	INSL3 promotes macrophage polarization to an immunosuppressive phenotype via the cAMP downstream signaling pathway and Akt/mTOR pathway 2025 ·International Immunopharmacology ·Mengting Zhou, (unknown), Cuiping Li, (unknown), (unknown), Wěi Li, Meiying Song, (unknown), Guixian Liu, Xinling Liang, Jie Liang, Bei Zhang, Luoyang Wang	1
3	Podocyte RIPK3 Deletion Improves Diabetic Kidney Disease by Attenuating NF‐κB p65 Driven Inflammation 2025 ·Advanced Science ·Luan Li, Jiaying Li, Ruizhao Li, Xingchen Zhao, Yuanhan Chen, (unknown), Yang Yan, (unknown), (unknown), Li Zhang, Xinling Liang	1
4	994MO The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/Rα payloads, in patients with advanced solid tumors 2024 ·Annals of Oncology ·Yi Shen, (unknown), Aiping Qin, Yiting Qiu, Fang Tang, Xinling Liang, Ye Li, Qunyou Tan, Ronghua Zhao, Xue Bai, (unknown)	0
5	Autophagic inhibitor ROC-325 ameliorates glomerulosclerosis and podocyte injury via inhibiting autophagic flux in experimental FSGS mice 2024 ·European Journal of Pharmacology ·(unknown), (unknown), Luan Li, (unknown), Hong Zhang, (unknown), (unknown), (unknown), Qingying Shi, (unknown), (unknown), Xingchen Zhao, (unknown), (unknown), Yuanhan Chen, Li Zhang, Xinling Liang	1
6	The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients 2024 ·Renal Failure ·Xinju Zhao, Liangying Gan, Fan Fan Hou, Xinling Liang, Xiaonong Chen, Yuqing Chen, Zhaohui Ni, Li Zuo	1
7	Enarodustat for the Treatment of Anemia in Chinese Patients with Non-Dialysis Chronic Kidney Disease: A Phase 3 Trial 2024 ·SHILAP Revista de lepidopterología ·Xinling Liang, (unknown), Jianteng Xie, Yanning Zhang, Yinan Li, Xiaonong Chen, (unknown), (unknown), (unknown), Yunhua Liao, Hui Xu, Ankui Yang, Hongwen Zhao, Zichen Liu, Lili Yang, Xueqing Yu	0
8	Quantitative proteomics analysis reveals the protective role of S14G-humanin in septic acute kidney injury using 4D-label-free and PRM Approaches 2024 ·Biochemical and Biophysical Research Communications ·Qingying Shi, (unknown), Wenjing Cai, Yuanhan Chen, (unknown), Zhiming Ye, Zhilian Li, Xinling Liang	0
9	83P The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumors 2023 ·Annals of Oncology ·Yi Shen, (unknown), Aiping Qin, Yiting Qiu, Fang Tang, Xinling Liang, Ye Li, (unknown), Ronghua Zhao, Xue Bai, (unknown)	2
10	Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy 2023 ·Microbiology Spectrum ·(unknown), Chenfen Zhou, Na Jiao, Xinling Liang, Zhiming Ye, (unknown), Qiongqiong Yang, Hui Peng, Ying Tang, Chaoqun Niu, Guoping Zhao, Zefeng Wang, Guoqing Zhang, Xueqing Yu	7
11	Flot2 acts as a novel mediator of podocyte injury in proteinuric kidney disease 2022 ·International Journal of Biological Sciences ·Chunping Yu, Hong Zhang, Shuangxin Liu, Ruizhao Li, Xingchen Zhao, Yuanhan Chen, Zhuo Li, Jianchao Ma, Wenjian Wang, Zhiming Ye, Xinling Liang, Li Zhang, Wei Shi	6
12	Effects of predilution hemodiafiltration-induced intradialytic left ventricular systolic dysfunction compared to high-flux hemodialysis 2022 ·International Urology and Nephrology ·(unknown), (unknown), Chuan Yang, Sijia Li, Zhuo Li, (unknown), Ting Lin, Feng Wen, (unknown), Zhiming Ye, Wenjian Wang, Xinling Liang, Shuangxin Liu, Wei Shi	1
13	Aberrant NAD synthetic flux in podocytes under diabetic conditions and effects of indoleamine 2,3-dioxygenase on promoting de novo NAD synthesis 2022 ·Biochemical and Biophysical Research Communications ·Yuhua Zhang, Xingchen Zhao, (unknown), Yan Yang, Luan Li, Yingwen Chen, (unknown), Qingying Shi, Zhilian Li, Yanhua Wu, Li Zhang, Ruizhao Li, (unknown), Xinling Liang, Yuanhan Chen	5
14	Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPS 2022 ·BMC Nephrology ·Xinju Zhao, (unknown), Liangying Gan, Fan Fan Hou, Xinling Liang, Zhaohui Ni, Xiaonong Chen, Yuqing Chen, Keith McCullough, Bruce Robinson, Li Zuo	8
15	Blood flow rate: An independent risk factor of mortality in Chinese hemodialysis patients 2021 ·Seminars in Dialysis ·Xinju Zhao, (unknown), Liangying Gan, Fan Fan Hou, Xinling Liang, Zhaohui Ni, Xiaonong Chen, Keith McCullough, Junhui Zhao, Bruce Robinson, Yuqing Chen, Li Zuo	6
16	Thrombocytopenia Predicts Mortality in Chinese Hemodialysis Patients: An Analysis of the China DOPPS 2021 ·Journal of the American Society of Nephrology ·Xinju Zhao, (unknown), Liangying Gan, Fan Fan Hou, Xinling Liang, Zhaohui Ni, Xiaonong Chen, Yuqing Chen, Keith McCullough, Bruce Robinson, Li Zuo	0
17	Prevalence of Concomitant Coronary Artery Disease and Its Impact on Acute Kidney Injury for Chinese Adult Patients Undergoing Valvular Heart Surgery 2019 ·Cardiology ·Zhiyong Xie, (unknown), Jimei Chen, Yanhua Wu, Shixin Chen, Zhilian Li, Zhiming Ye, (unknown), Shuangxin Liu, Lei Fu, Yuanhan Chen, Xinling Liang	4
18	Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross‐sectional survey 2017 ·Journal of Viral Hepatitis ·Ling Ning, Wanying Lin, Xingbin Hu, Rong Fan, Xinling Liang, (unknown), (unknown), Rui Yu, Jian Sun, Jinlin Hou	11
19	Flow control effect of necrostatin-1 on cell death of the NRK-52E renal tubular epithelial cell line 2017 ·Molecular Medicine Reports ·(unknown), Yiming Tao, Xinling Liang, Yuanhan Chen, Li Zhang, Fen Jiang, Shuangxin Liu, Zhiming Ye, Zhilian Li, Wei Shi	6
20	[The sensitivity and accuracy of RIFLE and AKIN criteria for acute kidney injury diagnosis in intensive care unit patients]. 2011 ·PubMed ·Fen Jiang, Yuanhan Chen, Xinling Liang, Lixia Xu, (unknown), (unknown), Shuangxin Liu, Wei Shi	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact